247 results on '"Berstein, Lev"'
Search Results
2. Role of Endocrine-Genotoxic Switchings in Cancer and Other Human Diseases : Basic Triad
3. Lectin-Induced Agglutination Method of Urinary Exosomes Isolation Followed by mi-RNA Analysis: Application for Prostate Cancer Diagnostic
4. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
5. More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin
6. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
7. General Conclusion
8. Markers of Lymphocytic-Macrophagal Infiltration and Their Association With the Receptor Phenotype and Proliferative Activity of Tumor Tissue in Various Molecular-Biological Types of Endometrial Cancer
9. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma
10. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
11. High baby birth weight and risk of hormone-associated cancer in mothers: the cancer–cardiovascular disease dichotomy and its possible causes
12. Prevalence of Familial Diabetes Differs between Type 2 Diabetes Mellitus Patients with Cancer and Those without Cancer
13. CYP19 gene polymorphism in endometrial cancer patients
14. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes
15. Dark and light side of obesity: mortality of metabolically healthy obese people
16. Endocrinology of breast cancer: results, tasks and hopes
17. Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells
18. Metformin Restores the Drug Sensitivity of MCF-7 Cells Resistant Derivates via the Cooperative Modulation of Growth and Apoptotic-Related Pathways
19. SUN-133 Intratumoral Expression of Steroid Receptors, CD68+ Macrophages and Mdm2 in Different Molecular-Biological Types of Endometrial Cancer
20. Aromatase, CYP1B1 and Fatty Acid Synthase Expression in Breast Tumors of BRCA1 Mutation Carriers
21. Dissimilar associations of same metabolic parameters with main chronic noncommunicable diseases (cancer vs some other NCDs)
22. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
23. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
24. The Phenomenon of the Switching of Estrogen Effects and Joker Function of Glucose: Similarities and Relation to Age-Associated Pathology and Approaches to Correction
25. Central and Peripheral Effects of Insulin/IGF-1 Signaling in Aging and Cancer: Antidiabetic Drugs as Geroprotectors and Anticarcinogens
26. Re: Effect of Long-Term Estrogen Deprivation on Apoptotic Responses of Breast Cancer Cells to 17β-Estradiol and The Two Faces of Janus: Sex Steroids as Mediators of Both Cell Proliferation and Cell Death
27. Estrogen replacement therapy (ERT) in patients with cervical cancer.
28. Is cancer incidence modified by SGLT2 inhibitors?
29. Endocrinology of obese and nonobese endometrial cancer patients: is there role of tumor molecular-biological type?
30. MON-309 Intratumoral Proliferation and Proinflammatory Macrophages in Obese and Non-Obese Patients with Different Molecular-Biological Types of Endometrial Cancer
31. New developments of metformin in the clinical cancer area
32. Mixed blessings for middle-aged mothers
33. Birthweight as risk factor for breast cancer
34. Metformin: not only per os
35. Endometrial cancer evolution: new molecular-biologic types and hormonal-metabolic shifts
36. Adipokines, myokines and cytokines in endometrial cancer patients: relations to obesity phenotype of excessive body mass and features of the tumor
37. Body mass and cancer: genetics, endocrinology… and more
38. Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues
39. Features of omental adipose tissue in endometrial cancer patients with ‘standard’ or ‘metabolically healthy’ obesity: associations with tumor process characteristics
40. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer
41. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
42. Insulinemia, heterogeneity of obesity and the risk of different types of endometrial cancer: existing evidence
43. Thyroid cancer and insulin resistance: is it important?
44. Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
45. Features of endometrial cancer in patients with ‘metabolically healthy’ versus ‘standard’ obesity: the decreasing frequency of metabolically healthy obesity
46. Cancer endocrinology: noticeable developments in the last decade
47. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic
48. Frequency of type 2 diabetes in family and it’s changes in diabetic patients affected or not affected with cancer
49. Potential and real ‘antineoplastic’ and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females
50. The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.